pic

Cardiac PET Imaging, it’s here.

How to Refer a Patient

pic

ONLINE

You can refer your patient for a cardiac PET scan appointment via our online patient portal.
pic

BY PHONE OR FAX

Refer your patient for a cardiac PET scan appointment by directly calling our office.

Leasing Programs

We offer CMS-approved flexible block time leasing arrangements for practices or groups of any size. Contact us for more information.

Indications for Cardiac PET

Cardiac PET: Myocardial Perfusion Imaging- Appropriate Use Criteria
Detection of CAD in the symptomatic patient:

▪️ Evaluation of Ischemic Equivalent (Non-Acute)
▪️ Acute Chest Pain
▪️ Acute chest pain (rest imaging only )

Risk Assessment: Preoperative Evaluation for Non-Cardiac Surgery without Active Cardiac Conditions*
▪️ Intermediate-Risk Surgery
▪️ Vascular Surgery

Detection of CAD/Risk Assessment without Ischemic Equivalent

▪️ Asymptomatic- High CHD Risk (ATP III Risk Criteria)
▪️ New-Onset or Newly diagnosed Heart Failure with LV Systolic Dysfunction without Ischemic Equivalent
▪️ Ventricular Tachychardia
▪️ Syncope with Intermediate or High CHD risk (ATP III Risk Criteria)
▪️ Troponin elevation without additional evidence of acute coronary syndrome

Risk Assessment: Within 3 months of an Acute Coronary Syndrome
1. STEMI
2. UA/NSTEMI
3. Risk Assessement: Post Revascularization (PCI or CABG)
▫️ Symptomatic
▫️ Asymptomatic- Incomplete Revascularization or greater than or equal to 5 years post CABG

Assessment of Viability/Ischemia
▪️ Ischemic Cardiomyopathy
▪️ Assessment of Viability for patient eligible for revascularization.                    

Evaluation of Left Ventricular Function
▪️ In absence of recent reliable diagnostic information from another imaging modality
▪️ Baseline and serial measures after key therapeutic milestones or evidence of toxicity from potentially cardiotoxic therapy

Risk Assessment with prior test results and/or known chronic stable CAD
▪️ Equivocal, borderline or discordant stress testing where obstructive CAD remains a concern. An inconclusive test is a test(s) whose results are equivocal, technically uninterpretable, or discordant with a patient’s other clinical data
▪️ New or worsening symptoms- Abnormal coronary angiography OR abnormal prior stress imaging study
▪️ Coronary stenosis or anatomic abnormality of uncertain significance
▪️ Asymptomatic, High CHD risk, Agatston score between 100-400
▪️ Asymptomatic, Agatston score greater than 400
▪️ Asymptomatic, Intermediate-Risk Duke Treadmill Score
▪️ Asymptomatic, High-Risk Duke Treadmill Score

Cardiac PET: Myocardial Viability

The applications for Cardiac Viability Imaging with FDG PET are:

1. The identification of patients with partial loss of heart muscle movement or hibernating myocardium is important in selecting candidates with compromised ventricular function to determine appropriateness for revascularization.
2. Distinguish between dysfunctional but viable myocardial tissue and scar tissue in order to affect management decisions in patients with ischemic cardiomyopathy and left ventricular dysfunction.

Medicare covers FDG PET for the determination of:

1. Myocardial viability as a primary or initial diagnostic study prior to revascularization, or following an inconclusive SPECT. Studies performed by full and partial ring scanners are covered.
2. Limitations: In the event a patient receives a SPECT test with inconclusive results, a PET scan may be covered. However, if a patient receives a FDG PET study with inconclusive results, a follow up SPECT test is not covered.

Cardiac PET Publications

CORONARY FLOW RESERVE


CORONARY ARTERY DISEASE


MYOCARDIAL VIABILITY


CARDIAC SARCOID


PET VS SPECT


pic
818.925.2480
pic
info@cardiacpetpartners.com
pic
16550 Ventura Blvd. Suite 122 Encino, CA 91436